NEW RAY MEDIC released its interim results, with a net loss of HKD 7.454 million, an increase of 82.3% year-on-year
I'm PortAI, I can summarize articles.
NEW RAY MEDIC released its mid-2025 performance, with revenue of HKD 44.701 million, a year-on-year increase of 167.4%. However, the net loss was HKD 7.454 million, a year-on-year increase of 82.3%, with a basic loss per share of HKD 0.045. The revenue growth was mainly due to the launch of new products, but was affected by China's antimicrobial drug management policies, leading to a decline in some demand
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments